Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. FDA Drug Information Updates

New Safe Use Requirements for Long-Acting Beta-Agonists (LABAs)

ReachMD Healthcare Image
Restart
Resume
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Comments
  • Overview

    FDA is recommending new safety measures to improve the safe use of long acting beta agonists (LABAs).

Recommended
Details
Comments
  • Overview

    FDA is recommending new safety measures to improve the safe use of long acting beta agonists (LABAs).

Schedule27 Nov 2024